1 | Case | 2% | |
2 | Report | 1.43% | |
3 | Cancer | 1.14% | |
4 | Study | 1.14% | |
5 | Disease | 1.05% | |
6 | Therapy | 0.67% | |
7 | Renal | 0.67% | |
8 | Health | 0.67% | |
9 | New | 0.57% | |
10 | Review | 0.57% | |
11 | According | 0.57% | |
12 | Alzheimer’s | 0.48% | |
13 | Risk | 0.48% | |
14 | Treatment | 0.48% | |
15 | Clinical | 0.38% | |
16 | Carcinoma | 0.38% | |
17 | Rare | 0.38% | |
18 | Bone | 0.38% | |
19 | Artery | 0.38% | |
20 | Research | 0.38% | |
21 | Potential | 0.38% | |
22 | Management | 0.38% | |
23 | Detection | 0.29% | |
24 | Muscle | 0.29% | |
25 | ADHD | 0.29% | |
26 | Dual-target | 0.29% | |
27 | Randomized | 0.29% | |
28 | Hospital | 0.29% | |
29 | Role | 0.29% | |
30 | Lung | 0.29% | |
31 | Adjuvant | 0.29% | |
32 | Early | 0.29% | |
33 | May | 0.29% | |
34 | Breast | 0.29% | |
35 | Weight | 0.29% | |
36 | Mediterranean | 0.29% | |
37 | Female | 0.29% | |
38 | Loss | 0.29% | |
39 | Advanced | 0.29% | |
40 | Associated | 0.29% | |
41 | Patients | 0.29% | |
42 | Reveals | 0.29% | |
43 | Distal | 0.29% | |
44 | Trial | 0.29% | |
45 | HIV | 0.29% | |
46 | US | 0.29% | |
47 | Cell | 0.29% | |
48 | Cholesterol | 0.29% | |
49 | Cardiovascular | 0.29% | |
50 | NSCLC | 0.29% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
Novel Molecular Assay Guides Adjuvant Chemo in NSCLC
HMP Global Learning Network
2025-06-01 02:30:08
Molecular Assay Identifies Patients With Early NSCLC Likely to Benefit From Adjuvant Chemotherapy
The ASCO Post
2025-06-01 00:00:04